Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials.

نویسندگان

  • Punam Mangtani
  • Ibrahim Abubakar
  • Cono Ariti
  • Rebecca Beynon
  • Laura Pimpin
  • Paul E M Fine
  • Laura C Rodrigues
  • Peter G Smith
  • Marc Lipman
  • Penny F Whiting
  • Jonathan A Sterne
چکیده

BACKGROUND Randomized trials assessing BCG vaccine protection against tuberculosis have widely varying results, for reasons that are not well understood. METHODS We examined associations of trial setting and design with BCG efficacy against pulmonary and miliary or meningeal tuberculosis by conducting a systematic review, meta-analyses, and meta-regression. RESULTS We identified 18 trials reporting pulmonary tuberculosis and 6 reporting miliary or meningeal tuberculosis. Univariable meta-regression indicated efficacy against pulmonary tuberculosis varied according to 3 characteristics. Protection appeared greatest in children stringently tuberculin tested, to try to exclude prior infection with Mycobacterium tuberculosis or sensitization to environmental mycobacteria (rate ratio [RR], 0.26; 95% confidence interval [CI], .18-.37), or infants (RR, 0.41; 95% CI, .29-.58). Protection was weaker in children not stringently tested (RR, 0.59; 95% CI, .35-1.01) and older individuals stringently or not stringently tested (RR, 0.88; 95% CI, .59-1.31 and RR, 0.81; 95% CI, .55-1.22, respectively). Protection was higher in trials further from the equator where environmental mycobacteria are less and with lower risk of diagnostic detection bias. These associations were attenuated in a multivariable model, but each had an independent effect. There was no evidence that efficacy was associated with BCG strain. Protection against meningeal and miliary tuberculosis was also high in infants (RR, 0.1; 95% CI, .01-.77) and children stringently tuberculin tested (RR, 0.08; 95% CI, .03-.25). CONCLUSIONS Absence of prior M. tuberculosis infection or sensitization with environmental mycobacteria is associated with higher efficacy of BCG against pulmonary tuberculosis and possibly against miliary and meningeal tuberculosis. Evaluations of new tuberculosis vaccines should account for the possibility that prior infection may mask or block their effects.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Protocol for a Systematic Review: Bacillus Calmette- Guerin (BCG) Revaccination and Protection Against Tuberculosis

Background: The length of the protective efficacy of BCG vaccine plays an important role in the establishment of vaccination policies. Revaccination with two or more doses is supposed to boost up the immunity. However, the effectiveness of BCG revaccination has been questioned. It was argued that revaccination may increase the rate of tuberculin conversion but does it result in more sustained r...

متن کامل

Effectiveness of Bacillus Calmette-Guerin for Tuberculosis Prevention Among Chinese People: Systematic Review and Meta-analysis

Background: Our previous study showed that the protective effect of Bacillus Calmette-Guerin (BCG) declined with time, which is supported by a following study saying "BCG vaccination protection against tuberculosis varies between populations, to an extent that cannot be attributed to chance alone". Objective: To investigate BCG protective effect among Chinese people, so as to update the develop...

متن کامل

BCG vaccine and pulmonary tuberculosis

Tuberculosis (TB) is one of the most important public health problems in the world and has been declared as a global emergency by the World Health Organization (WHO) in 1993. Bacillus Calmette-Guérin (BCG) is one of the first developed vaccines to prevent TB. Unfortunately, BCG vaccine has had a limited duration of protection and has shown controversial and variable levels of efficacy, especial...

متن کامل

ب‌ث‌ژ تنها واکسن موجود جهت مقابله با بیماری سل: مقاله مروری

Background: Despite advances in the vaccinology and chemotherapy in the past century, tuberculosis is still responsible for two million deaths every year. Emergence of multi-drug resistant strain and coinfection of TB-HIV make it a serious concern. Treatment and control of tuberculosis is a great health burden in every community. Active tuberculosis in children has very severe consequences espe...

متن کامل

Does the efficacy of BCG decline with time since vaccination?

OBJECTIVE To investigate whether the protective efficacy of bacille Calmette-Guérin (BCG) against tuberculosis decreases with time since vaccination. DESIGN A quantitative review of all 10 randomized trials of BCG against tuberculosis in purified protein derivative (PPD)-negative individuals, that presented data for discrete periods. For each trial, we derived log rate ratios for the annual c...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

دوره 58 4  شماره 

صفحات  -

تاریخ انتشار 2014